Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: a 15-year follow-up study Source: Eur Respir J, 55 (1) 1900798; 10.1183/13993003.00798-2019 Year: 2020
Long-term follow-up study of patients with pneumoconiosis complicated by nontuberculous mycobacterial lung disease: report of four cases Source: Eur Respir J 2001; 18: Suppl. 33, 443s Year: 2001
Clinical outcome of multiple nontuberculous mycobacteria infection among people with bronchiectasis in Taiwan: a cohort study Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020
Prevalence of non-tuberculous mycobacterial disease among patients evaluated for pulmonary tuberculosis in Iraq 2015-2018 Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019
Outcomes of patients undergoing treatment for non-tuberculous mycobacteria lung disease Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019
Comparative study of clinical features between elderly and non-elderly patients with pulmonary nontuberculous mycobacterial disease Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis Year: 2021
Features of community acquired pneumonia in patients hospitalized in the institute for pulmonary diseases over a five-year period Source: Eur Respir J 2006; 28: Suppl. 50, 165s Year: 2006
Chronic pulmonary aspergillosis in France: prevalence, associated chronic pulmonary diseases and prognosis in a 10-year retrospective study of the French nationwide administrative hospital database. Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019
The impact of new ATS/IDSA guideline for nontuberculous mycobacterial disease on the diagnosis of nontuberculous mycobacterial lung disease in Korea Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008
Ocular manifestations in unselected group of sarcoid patients hospitalised in the national tuberculosis and lung diseases research institute Source: Eur Respir J 2002; 20: Suppl. 38, 435s Year: 2002
Analysis of mortality incidence in patients with pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 555s Year: 2002
Population-based survey of antimycobacterial drug use among patients with non-tuberculosis mycobacterial pulmonary disease Source: ERJ Open Res, 6 (1) 00097-2019; 10.1183/23120541.00097-2019 Year: 2020
Cardiovascular disease risk in patients with nontuberculous mycobacteria disease treated with macrolide Source: International Congress 2017 – Clinical update on bronchiectasis and nontuberculous mycobacteria (NTM) infections Year: 2017
Prevalence, risk factors and prognosis of nontuberculous mycobacterial infection among people with bronchiectasis: a population survey Source: Eur Respir J, 51 (5) 1702469; 10.1183/13993003.02469-2017 Year: 2018
Aero-environmental bacteriological survey of respiratory non-tuberculosis mycobacterial disease patients Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016
Patient reported outcomes for non-tuberculous mycobacterial disease Source: Eur Respir J, 55 (1) 1902204; 10.1183/13993003.02204-2019 Year: 2020
Epidemiological features of nosocomial tuberculosis in patients with pulmonary tuberculosis in TB hospital Source: International Congress 2018 – Tuberculosis transmission and screening strategies Year: 2018
Cure rates in nontuberculous mycobacterial pulmonary disease Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019
Survival and risk factors of mortality among defaulters from treatment of pulmonary tuberculosis Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview Year: 2012
The prevalence and clinical profile of non-tuberculous mycobacterial pulmonary infection in Singapore Source: International Congress 2018 – Respiratory epidemiology: from infectious diseases to lung cancer Year: 2018